Tempo differito
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
245 EUR | -0,08% | -2,62% | +15,68% |
07:00 | I selezionatori di titoli europei si rivolgono alla vecchia scuola per cavalcare la prossima ondata dell'AI | RE |
21/05 | Roche: 57 dipendenti esposti a sostanza cancerogena | AW |
Attività
Vendite per attività
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Pharmaceuticals
76,6
%
| 48 628 | 73,2 % | 46 279 | 76,6 % | -4,83% |
Diagnostics
23,4
%
| 17 798 | 26,8 % | 14 162 | 23,4 % | -20,43% |
Vendite per regione
CHF in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
46,9
%
| 29 313 | 44,1 % | 28 352 | 46,9 % | -3,28% |
Rest of Europe
16,1
%
| 10 328 | 15,5 % | 9 703 | 16,1 % | -6,05% |
Rest of Asia
14,7
%
| 9 852 | 14,8 % | 8 890 | 14,7 % | -9,76% |
Japan
7,4
%
| 6 452 | 9,7 % | 4 464 | 7,4 % | -30,81% |
Latin America
4,9
%
| 2 870 | 4,3 % | 2 971 | 4,9 % | +3,52% |
Germany
4,8
%
| 3 318 | 5,0 % | 2 893 | 4,8 % | -12,81% |
Africa, Australia and Oceania
2,0
%
| 1 520 | 2,3 % | 1 212 | 2,0 % | -20,26% |
Switzerland
1,8
%
| 1 671 | 2,5 % | 1 118 | 1,8 % | -33,09% |
Rest of North America
1,4
%
| 1 102 | 1,7 % | 838 | 1,4 % | -23,96% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Chief Executive Officer | 49 | 01/01/03 | |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 01/04/11 |
Pascale Schmidt
CMP | Compliance Officer | 51 | 01/01/20 |
Levi Garraway
CTO | Chief Tech/Sci/R&D Officer | - | - |
Bruno Eschli
IRC | Investor Relations Contact | - | - |
Silke Hörnstein
PRN | Corporate Officer/Principal | 49 | 01/01/15 |
Annette Luther
SEC | Corporate Secretary | 54 | 01/04/20 |
General Counsel | 60 | 01/04/20 | |
Human Resources Officer | 57 | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 03/03/15 |
Director/Board Member | 59 | - | |
Director/Board Member | 66 | 01/01/96 | |
Patrick Frost
BRD | Director/Board Member | 56 | 17/03/20 |
Hans Clevers
PRN | Corporate Officer/Principal | 67 | 05/03/19 |
Severin Schwan
CHM | Chairman | 57 | 01/01/08 |
Anita Hauser
BRD | Director/Board Member | 55 | 14/03/17 |
Director/Board Member | 71 | 03/03/15 | |
Director/Board Member | 58 | 01/03/16 | |
Joerg Duschmale
BRD | Director/Board Member | 40 | 17/03/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 106 691 000 | 28 989 189 ( 27,17 %) | 0 | 88,91 % |
Azione B | 1 | 702 562 700 | 690 549 674 ( 98,29 %) | 12 011 755 ( 1,710 %) |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
1 005 670 000 | 59.89% | 32 272 955 970 $ | |
ROCHE HOLDING AG 1.43% | 10 073 029 | 1.43% | 2 422 842 800 $ |
2 744 120 | 8.15% | 33 917 323 $ | |
454 961 | 3.02% | 9 636 074 $ | |
ALIGOS THERAPEUTICS, INC. 15.19% | 11 025 941 | 15.19% | 9 019 220 $ |
1 893 | 0.06% | 1 486 $ |
Coordinate società
Società del gruppo
Nome | Categoria e settore |
---|---|
Viewics India Pvt Ltd.
| |
Roche Finance Europe BV
|
Finance/Rental/Leasing
|
Roche Financial Management Ltd.
| |
Roche Catalyst Investments Ltd.
| |
Roche Financial Investments Ltd.
| |
Roche Intertrade Ltd.
| |
Roche Pharmholding BV
Roche Pharmholding BV Medical DistributorsDistribution Services Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The company is based in Woerden, Netherlands. |
Medical Distributors
|
Roche Diagnostics India Pvt Ltd.
Roche Diagnostics India Pvt Ltd. Medical SpecialtiesHealth Technology Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers. |
Medical Specialties
|
Roche Diagnostics Belgium NV
Roche Diagnostics Belgium NV BiotechnologyHealth Technology Part of Roche Holding AG, Roche Diagnostics Belgium NV is a Belgian company that develops innovative products and services for the prevention, diagnosis, monitoring, screening, and treatment of diseases. Roche Diagnostics Belgium is based in Diegem, Belgium, and was founded in 1958. The company offers next-generation sequencing products and in vitro diagnostics that are an integral part of decision-making along the entire continuum of a patient's health or disease. The CEO is Thomas Schinecker. |
Biotechnology
|
Settore
Vendite per attività
Vendite per regione
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+37,78% | 723 Mrd | |
+32,82% | 598 Mrd | |
-3,51% | 364 Mrd | |
+19,94% | 331 Mrd | |
+5,14% | 288 Mrd | |
+16,64% | 244 Mrd | |
+10,63% | 210 Mrd | |
+9,32% | 169 Mrd | |
-0,80% | 162 Mrd |
- Borsa valori
- Azioni
- Azione ROG
- Azione RHO
- Società Roche Holding AG